LCM
DGX icon

Laurion Capital Management’s Quest Diagnostics DGX Stock Holding History

Laurion Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-68,600
Closed -$6.3M – 1351
2016
Q4 		$6.3M Buy
+68,600
New +$5.91M 0.06% 307

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Laurion Capital Management's DGX Position: Q4 2020 in Review

Laurion Capital Management sold out of Quest Diagnostics (DGX) in Q4 2020, closing a stake of 11,447 shares — an estimated $1.31M sold.

Laurion Capital Management first reported a position in DGX in Q3 2015 and held it in 11 quarters. The position peaked at $6.89M in Q3 2017. 812 funds tracked by Wall St. Rank hold DGX as of Q4 2020.

  • Laurion Capital Management reported no remaining Quest Diagnostics position as of Q4 2020 after selling out during the quarter.
  • Laurion Capital Management sold 11,447 Quest Diagnostics shares in Q4 2020, an estimated $1.31M.
  • Laurion Capital Management first reported a position in Quest Diagnostics in Q3 2015 and held it in 11 quarters.
  • Laurion Capital Management's Quest Diagnostics position peaked at $6.89M in Q3 2017.
  • 812 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2020.

Based on Laurion Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.